Remove solutions bioanalytical-solutions
article thumbnail

The Power of Personalization Amid the Changing CRO Landscape

Worldwide Clinical Trials

These survey results also highlight the importance of evaluating a variety of potential CRO partners of different sizes to choose the best match for your clinical development goals and corporate culture. At Worldwide, we understand that every program is different, which means every drug development path forward will be unique.

article thumbnail

The evolution of clinical trials: the pharmaphorum podcast

pharmaphorum

As executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Fern managed all commercial and day-to-day operations of the company’s 300-bed clinic and state-of-the-art bioanalytical laboratory, growing EBITDA from 1 percent to 13 percent. About Syneos Health.